Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jan;214(1):4-10.
doi: 10.1192/bjp.2018.122. Epub 2018 Jun 28.

Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis

Affiliations
Meta-Analysis

Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis

Ymkje Anna de Vries et al. Br J Psychiatry. 2019 Jan.

Abstract

Background: Improvement in depression within the first 2 weeks of antidepressant treatment predicts good outcomes, but non-improvers can still respond or remit, whereas improvers often do not.AimsWe aimed to investigate whether early improvement of individual depressive symptoms better predicts response or remission.

Method: We obtained individual patient data of 30 trials comprising 2184 placebo-treated and 6058 antidepressant-treated participants. Primary outcome was week 6 response; secondary outcomes were week 6 remission and week 12 response and remission. We compared models that only included improvement in total score by week 2 (total improvement model) with models that also included improvement in individual symptoms.

Results: For week 6 response, the area under the receiver operating characteristic curve and negative and positive predictive values of the total improvement model were 0.73, 0.67 and 0.74 compared with 0.77, 0.70 and 0.71 for the item improvement model. Model performance decreased for week 12 outcomes. Of predicted non-responders, 29% actually did respond by week 6 and 43% by week 12, which was decreased from the baseline (overall) probabilities of 51% by week 6 and 69% by week 12. In post hoc analyses with continuous rather than dichotomous early improvement, including individual items did not enhance model performance.

Conclusions: Examining individual symptoms adds little to the predictive ability of early improvement. Additionally, early non-improvement does not rule out response or remission, particularly after 12 rather than 6 weeks. Therefore, our findings suggest that routinely adapting pharmacological treatment because of limited early improvement would often be premature.Declaration of interestNone.

Keywords: Antidepressants; depression; early improvement; individual patient data meta-analysis; treatment response.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: None.

Figures

Fig. 1
Fig. 1
Actual probability of response at week 6 according to participants' predicted outcome (non-response versus response) for each model. Results are based on the test data-set. The dashed line indicates the baseline probability of response. The models predicted non-response for 42% (baseline), 38% (total improvement), 46% (item improvement) and 47% (item interactions) of participants.
Fig. 2
Fig. 2
Proportion of participants who responded or remitted according to the percentage improvement from baseline. Error bars (dashed lines) indicate the 95% CIs.

References

    1. National Institute for Health and Care Excellence. Depression: The NICE Guideline on the Treatment and Management of Depression in Adults (CG90) NICE, 2010.
    1. Spijker J, Bockting CLH, Meeuwissen JAC, van Vliet IM, Emmelkamp PMG, Hermens MLM, et al. Multidisciplinaire richtlijn Depressie (Derde revisie) : Richtlijn voor de diagnostiek, behandeling en begeleiding van volwassen patiënten met een depressieve stoornis. Trimbos-Instituut, 2013.
    1. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder American Psychiatric Association, 2010.
    1. Undurraga J, Baldessarini RJ. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 2012; 37: 851–64. - PMC - PubMed
    1. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: a systematic review and meta-analysis. Arch Gen Psychiatry 2006; 63: 1217–23. - PMC - PubMed

Publication types

Substances